Drug Buyers' Retooled $34M Celgene Deal Wins Initial OK
Law360 (May 21, 2020, 5:12 PM EDT) -- A New Jersey federal judge has given the preliminary green light to a $34 million deal between drug buyers and Bristol-Myers Squibb unit Celgene over allegations the drugmaker illegally monopolized a pair of cancer treatments.
U.S. District Judge Madeline Cox Arleo issued a brief decision Wednesday finding the deal "is sufficiently within the range of reasonableness" and called for a proposed class of drug buyers, including consumers, cities and union benefit funds, to start putting together a plan to alert other potential class members of the settlement.
Wednesday's stamp of approval comes a few months after Celgene astonished drug buyers by torpedoing...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!